Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEFOX: D,L-methadone + mFOLFOX6 in Advanced Colorectal Cancer
NCT05212012Phase 2Active, not recruiting
- Sponsor
- AIO-Studien
- Start
- Feb 2022
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methadone in colorectal cancer (CRC), sponsored by AIO-Studien. Started Feb 2022; status: active, not recruiting.
02
Drugs
methadone
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT05212012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05212012.